126 related articles for article (PubMed ID: 18845997)
21. Primary scrotal cancer: disease characteristics and increasing incidence.
Wright JL; Morgan TM; Lin DW
Urology; 2008 Nov; 72(5):1139-43. PubMed ID: 18799208
[TBL] [Abstract][Full Text] [Related]
22. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
[TBL] [Abstract][Full Text] [Related]
23. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groups.
Chen CH; Tzai TS; Huang SP; Wu HC; Tai HC; Chang YH; Pu YS
Urology; 2008 Dec; 72(6):1287-92. PubMed ID: 18372020
[TBL] [Abstract][Full Text] [Related]
25. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
[TBL] [Abstract][Full Text] [Related]
26. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
27. Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program.
Meeks JJ; Zhao LC; Cashy J; Kundu S
BJU Int; 2012 Mar; 109(6):831-4. PubMed ID: 21883856
[TBL] [Abstract][Full Text] [Related]
28. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
29. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
30. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
31. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
[TBL] [Abstract][Full Text] [Related]
32. National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias.
Fanning J; Gangestad A; Andrews SJ
Gynecol Oncol; 2000 Jun; 77(3):450-3. PubMed ID: 10831358
[TBL] [Abstract][Full Text] [Related]
33. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM
Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on survival of clinical stage I non-small-cell lung cancer.
Sigel K; Bonomi M; Packer S; Wisnivesky J
Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
[TBL] [Abstract][Full Text] [Related]
35. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales.
Tseng JH; Merchant E; Tseng MY
Surg Neurol; 2006 Sep; 66(3):258-63; discussion 263. PubMed ID: 16935629
[TBL] [Abstract][Full Text] [Related]
36. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
38. Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study.
Dutta Roy S; Philip J; Javle P
Int J Urol; 2005 Jul; 12(7):644-53. PubMed ID: 16045557
[TBL] [Abstract][Full Text] [Related]
39. Association of the California tobacco control program with declines in lung cancer incidence.
Barnoya J; Glantz S
Cancer Causes Control; 2004 Sep; 15(7):689-95. PubMed ID: 15280627
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
